The effectiveness of biofeedback therapy in children with monosymptomatic enuresis resistant to desmopressin treatment

Basit Öğe Kaydı
dc.authoridAlan, Cabir/0000-0002-6024-4475
dc.contributor.authorSancak, Eyup Burak
dc.contributor.authorAkbas, Alpaslan
dc.contributor.authorKurt, Omer
dc.contributor.authorAlan, Cabir
dc.contributor.authorErsay, Ahmet Resit
dc.date.accessioned2025-01-27T20:31:39Z
dc.date.available2025-01-27T20:31:39Z
dc.date.issued2016
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: To investigate the effect of biofeedback therapy on children with desmopressin-resistant primary monosymptomatic enuresis (MsE). Material and methods: The study comprised both retrospective and prospective sections. A total of 262 medical files of patients who were diagnosed as enuresis between November 2012 and January 2015 were retrospectively screened. Patients with neuropathic bladder, daytime voiding problems, anatomical pathology and enuresis-related diseases were excluded from the study. The demographic data and family characteristics of 29 children with desmopressin-resistant primary MsE were recorded. After biofeedback treatment patients whose frequency of enuretic episodes decrease by more than 50% were included in the successful biofeedback treatment group (SBTG), while other patients were categorized in the unsuccessful biofeedback treatment group (USGBT). The outcomes of uroflowmetry, voided volume, postvoiding residue (PVR) and total bladder volume/age-adjusted normal bladder capacity (TBV/NBC) were recorded before and at the sixth month of the treatment. Results: The mean age of 29 patients included in the study was 9.14 +/- 3.07 (6-15) years. Of patients, 16 were male (55.2%) and 13 were female (44.8%). Before biofeedback treatment the frequency of enuresis was 25.1 +/- 5.76 days/month, while after treatment this was calculated as 8.52 +/- 10.07 days/month. After treatment 8 patients (28.6%) achieved complete dryness. Twenty patients (69%), benefited from biofeedback (SBTG), while there were 9 patients (31%) in the USBTG group. There was no significant difference between the SBTG and USBTG groups in terms of age, body mass index and sex. The average bladder capacity of the patients increased from 215 mL to 257 mL after biofeedback treatment (p<0.001). The TBV/NBC value before treatment was 0.66, while after treatment it was 0.77 (p<0.001). There was a statistically significant difference between the SBTG and USBTG groups in terms of presence of MsE in mother, and both parents (p=0.001, p=0.016, respectively). Conclusion: Biofeedback therapy is a safe, simple, and minimally invasive treatment modality in children with MsE resistant to desmopressin treatment. This treatment, which was found to increase total bladder capacity, may be recommended for children with MsE when conventional desmopressin treatment fails.
dc.identifier.doi10.5152/tud.2016.39114
dc.identifier.endpage284
dc.identifier.issn2149-3235
dc.identifier.issn2149-3057
dc.identifier.issue4
dc.identifier.pmid27909622
dc.identifier.scopus2-s2.0-84996866885
dc.identifier.scopusqualityN/A
dc.identifier.startpage278
dc.identifier.trdizinid239597
dc.identifier.urihttps://doi.org/10.5152/tud.2016.39114
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/239597
dc.identifier.urihttps://hdl.handle.net/20.500.12428/23228
dc.identifier.volume42
dc.identifier.wosWOS:000388501500011
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofTurkish Journal of Urology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectAge adjusted normal bladder capacity
dc.subjectdesmopressin resistant enuresis
dc.subjectEMG biofeedback
dc.subjectmonosymptomatic enuresis
dc.subjecturoflowmetry
dc.titleThe effectiveness of biofeedback therapy in children with monosymptomatic enuresis resistant to desmopressin treatment
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu